OpenVSafe by OpenVAERS
Search V-safe

4GF-10425-32551

4 vaccinations 24 coded responses 52 check-ins 24 free-text entries 1 call case
Sex
Female
Age at first dose
66+
ZIP prefix
117 / NY
Registered
2021-02-11
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-11
    Registered in v-safe
  2. 2021-02-11
    Dose 1 — Moderna
  3. 2021-02-11
    Survey response — day 0, dose 1
    MedDRA: Injection site pain — Feeling: Good
    Free text: slight localized soreness at injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-02-12
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site pain, Pain — Feeling: Good · Site: Pain
    Free text: increased localized soreness around injection site overnight, sore with movement & to the touch
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-02-13
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site pain — Feeling: Good · Site: Pain
    Free text: soreness around injection site diminishing today
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-02-14
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site pain — Feeling: Good · Site: Pain
    Free text: injection site soreness almost gone
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-02-16
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site pain — Feeling: Good · Site: Pain
    Free text: soreness at injection site faded within 3 days
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-02-17
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site pain — Feeling: Good · Site: Pain
    Free text: soreness around injection site only lasted 3 days
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-02-18
    Health check-in — day 7, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  10. 2021-02-25
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-03-04
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-03-11
    Dose 2 — Moderna
  13. 2021-03-11
    Survey response — day 0, dose 2
    MedDRA: Injection site pain — Feeling: Good · Site: Pain
    Free text: escalating soreness around injection site.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-03-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site pain — Feeling: Good · Site: Pain
    Free text: escalated soreness around injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-03-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site pain — Feeling: Good
    Free text: injeciton site soreness dissipated in two days
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-03-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-03-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-03-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-03-18
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-03-25
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-04-01
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-04-08
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-17
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-22
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-06-12
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-09-09
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-11-04
    Dose 3 — Moderna
  28. 2021-11-05
    Survey response — days 1–6 daily, dose 3
    MedDRA: Injection site pain, Lymph node pain — Feeling: Good · Site: Pain
    Free text: Arm pain around the injection site & in the axillary lymph nodes.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2021-11-06
    Survey response — days 1–6 daily, dose 3
    MedDRA: Chills, Injection site pain, Lymph node pain — Feeling: Good · Site: Pain
    Free text: Slight chills approximately 18 hours post injection, 24 hours post, soreness at injection site diminished, axillary nodes remain sore, only marginally diminshed. s diminished
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-11-07
    Survey response — days 1–6 daily, dose 3
    MedDRA: Injection site discomfort, Lymph node pain, Lymphadenopathy — Feeling: Good
    Free text: axillary nodes soreness/pain & swelling persists, discomfort at injection site negligible
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-11-08
    Survey response — days 1–6 daily, dose 3
    MedDRA: Injection site pain, Lymph node pain, Lymphadenopathy — Feeling: Good
    Free text: Axillary nodes remain swollen, swelling only slightly diminished, soreness negligible. Injection site pain gone.
    MedDRA releases: 2024-11 · check-in free text available
  32. 2021-11-09
    Survey response — days 1–6 daily, dose 3
    MedDRA: Discomfort, Lymphadenopathy — Feeling: Good
    Free text: Axillary nodes swelling & discomfort not completely gone yet.
    MedDRA releases: 2024-11 · check-in free text available
  33. 2021-11-11
    Survey response — day 7, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: axillary nodes swellling diminished, but persists.
    MedDRA releases: 2024-11 · check-in free text available
  34. 2021-11-18
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  35. 2021-11-25
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-12-02
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-12-09
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-12-16
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  39. 2022-02-03
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  40. 2022-05-05
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-05-06
    Dose 4 — Moderna
  42. 2022-05-06
    Health check-in — day 0, dose 4
    Feeling: Good · None
    Adult check-in
  43. 2022-05-07
    Survey response — days 1–6 daily, dose 4
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain, Redness, Swelling
    Free text: Moderate pain and swelling in the axillary nodes on the side of the injection site
    MedDRA releases: 2024-11 · check-in free text available
  44. 2022-05-08
    Survey response — days 1–6 daily, dose 4
    MedDRA: Erythema, Injection site erythema, Injection site pruritus, Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain, Redness, Swelling, Itching
    Free text: Persistent redness, swelling, and pain of the axill ary nodes on the same side as the injection site. Spreading redness and increased itching around the injection site. ary nodes on the side of the injection site. Redness
    MedDRA releases: 2024-11 · check-in free text available
  45. 2022-05-09
    Survey response — days 1–6 daily, dose 4
    MedDRA: Erythema, Injection site erythema, Injection site pain, Injection site swelling, Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain, Redness, Swelling, Itching
    Free text: Axillary nodes (on the same side as the injection site) remain swollen, the redness is diminished, and the pain is abating. A ~3"x3" amorphic red patch surrounds the injection site which is still slightly swollen and sore.
    MedDRA releases: 2024-11 · check-in free text available
  46. 2022-05-10
    Survey response — days 1–6 daily, dose 4
    MedDRA: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain, Redness, Swelling, Itching
    Free text: Axillary nodes still swollen but less sore. Injection site soreness, itching, &swelling gone , redness persists but is diminished
    MedDRA releases: 2024-11 · check-in free text available
  47. 2022-05-11
    Survey response — days 1–6 daily, dose 4
    MedDRA: Injection site erythema, Lymph node pain, Lymphadenopathy, Pain — Feeling: Good · Site: Redness
    Free text: Axillary nodes on same side as injection site remain swollen, but no longer painful. Redness around injection site almost gone, soreness is gone.
    MedDRA releases: 2024-11 · check-in free text available
  48. 2022-05-12
    Survey response — days 1–6 daily, dose 4
    MedDRA: Injection site erythema, Lymphadenopathy — Feeling: Good · Site: Redness
    Free text: Axillary nodes swelling persists, but diminishing. Diffuse redness around injection site almost gone.
    MedDRA releases: 2024-11 · check-in free text available
  49. 2022-05-13
    Survey response — day 7, dose 4
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: axillary node swelling on the same side as the injection site persists but is diminishing.
    MedDRA releases: 2024-11 · check-in free text available
  50. 2022-05-21
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  51. 2022-05-27
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  52. 2022-06-03
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  53. 2022-06-10
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  54. 2022-06-17
    Survey response — day 42, dose 4
    MedDRA: Paranasal sinus discomfort — Feeling: Fair
    Free text: Sinus pressure, possible upper respiratory infection
    MedDRA releases: 2024-11 · check-in free text available
  55. 2022-08-05
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  56. 2022-11-04
    Survey response — 6 months, dose 4
    MedDRA: Cough, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: low grade fever, congestion, cough, followed by positive covid test · Healthcare visit (other): monoclodal antibody treatment
    MedDRA releases: 2024-11 · check-in free text available
  57. 2022-11-04
    Report sent to call center — 6 months, dose 4
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  58. 2022-11-08
  59. 2022-11-08
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  60. 2023-05-06
    Health check-in — 12 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-02-11Moderna
22021-03-11Moderna
32021-11-04Moderna No
42022-05-06Moderna No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 4 — day 0, dose 1

2021-02-11

Systemic reaction (other): slight localized soreness at injection site

Release 4 — days 1–6 daily, dose 1

2021-02-12

Systemic reaction (other): increased localized soreness around injection site overnight, sore with movement & to the touch

2021-02-13

Systemic reaction (other): soreness around injection site diminishing today

2021-02-14

Systemic reaction (other): injection site soreness almost gone

2021-02-16

Systemic reaction (other): soreness at injection site faded within 3 days

2021-02-17

Systemic reaction (other): soreness around injection site only lasted 3 days

Release 5 — day 0, dose 2

2021-03-11

Systemic reaction (other): escalating soreness around injection site.

Release 5 — days 1–6 daily, dose 2

2021-03-12

Systemic reaction (other): escalated soreness around injection site

2021-03-14

Systemic reaction (other): injeciton site soreness dissipated in two days

Release 10 — days 1–6 daily, dose 3

2021-11-05

Systemic reaction (other): Arm pain around the injection site & in the axillary lymph nodes.

2021-11-06

Systemic reaction (other): Slight chills approximately 18 hours post injection, 24 hours post, soreness at injection site diminished, axillary nodes remain sore, only marginally diminshed. s diminished

2021-11-07

Systemic reaction (other): axillary nodes soreness/pain & swelling persists, discomfort at injection site negligible

2021-11-08

Systemic reaction (other): Axillary nodes remain swollen, swelling only slightly diminished, soreness negligible. Injection site pain gone.

2021-11-09

Systemic reaction (other): Axillary nodes swelling & discomfort not completely gone yet.

Release 10 — day 7, dose 3

2021-11-11

Systemic reaction (other): axillary nodes swellling diminished, but persists.

Release 11 — days 1–6 daily, dose 4

2022-05-07

Systemic reaction (other): Moderate pain and swelling in the axillary nodes on the side of the injection site

2022-05-08

Systemic reaction (other): Persistent redness, swelling, and pain of the axill ary nodes on the same side as the injection site. Spreading redness and increased itching around the injection site. ary nodes on the side of the injection site. Redness cut off by CDC

2022-05-09

Systemic reaction (other): Axillary nodes (on the same side as the injection site) remain swollen, the redness is diminished, and the pain is abating. A ~3"x3" amorphic red patch surrounds the injection site which is still slightly swollen and sore.

2022-05-10

Systemic reaction (other): Axillary nodes still swollen but less sore. Injection site soreness, itching, &swelling gone , redness persists but is diminished

2022-05-11

Systemic reaction (other): Axillary nodes on same side as injection site remain swollen, but no longer painful. Redness around injection site almost gone, soreness is gone.

2022-05-12

Systemic reaction (other): Axillary nodes swelling persists, but diminishing. Diffuse redness around injection site almost gone.

Release 11 — day 7, dose 4

2022-05-13

Systemic reaction (other): axillary node swelling on the same side as the injection site persists but is diminishing.

Release 12 — day 42, dose 4

2022-06-17

Symptoms: Sinus pressure, possible upper respiratory infection

Release 12 — 6 months, dose 4

2022-11-04

Symptoms: low grade fever, congestion, cough, followed by positive covid test
Healthcare visit (other): monoclodal antibody treatment

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event · · ✓
SDCough · · ✓
SDParanasal sinus discomfort · · ✓
SDPyrexia · · ✓
SDRespiratory tract congestion · · ✓
SDSARS-CoV-2 test positive · · ✓
SROChills · · ✓
SRODiscomfort · · ✓
SROErythema · · ✓
SROInjection site discomfort · · ✓
SROInjection site erythema · · ✓
SROInjection site pain ✓ ✓ ✓
SROInjection site pruritus · · ✓
SROInjection site swelling · · ✓
SROLymph node pain · · ✓
SROLymphadenopathy · · ✓
SROPain ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…